Hudock Inc’s Quest Diagnostics DGX Stock Holding History

Hudock Inc’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100	Closed	-$12K	–	274
2022 Q3	$12K	Hold	100	–	–	﹤0.01%	498
2022 Q2	$13K	Hold	100	–	–	﹤0.01%	480
2022 Q1	$13K	Hold	100	–	–	﹤0.01%	506
2021 Q4	$17K	Sell	100 -200	-67%	-$30.4K	﹤0.01%	466
2021 Q3	$43K	Hold	300	–	–	0.01%	342
2021 Q2	$39K	Hold	300	–	–	0.01%	353
2021 Q1	$38K	Hold	300	–	–	0.01%	350
2020 Q4	$35K	Hold	300	–	–	0.01%	351
2020 Q3	$34K	Buy	+300	New	+$35.4K	0.01%	318
2016 Q3	–	Sell	-400	Closed	-$32K	–	570
2016 Q2	$32K	Hold	400	–	–	0.02%	280
2016 Q1	$28K	Hold	400	–	–	0.02%	300
2015 Q4	$28K	Hold	400	–	–	0.01%	273
2015 Q3	$24K	Hold	400	–	–	0.01%	289
2015 Q2	$29K	Hold	400	–	–	0.01%	281
2015 Q1	$31K	Hold	400	–	–	0.01%	283
2014 Q4	$27K	Hold	400	–	–	0.01%	277
2014 Q3	$24K	Hold	400	–	–	0.01%	299
2014 Q2	$23K	Hold	400	–	–	0.03%	310
2014 Q1	$23K	Hold	400	–	–	0.02%	286
2013 Q4	$21K	Hold	400	–	–	0.02%	301
2013 Q3	$25K	Hold	400	–	–	0.02%	235
2013 Q2	$24K	Buy	+400	New	+$23.8K	0.04%	233

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hudock Inc's DGX Position: Q4 2022 in Review

Hudock Inc sold out of Quest Diagnostics (DGX) in Q4 2022, closing a stake of 100 shares — an estimated $12K sold.

Hudock Inc first reported a position in DGX in Q2 2013 and held it in 22 quarters. The position peaked at $43K in Q3 2021. 878 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

Hudock Inc reported no remaining Quest Diagnostics position as of Q4 2022 after selling out during the quarter.
Hudock Inc sold 100 Quest Diagnostics shares in Q4 2022, an estimated $12K.
Hudock Inc first reported a position in Quest Diagnostics in Q2 2013 and held it in 22 quarters.
Hudock Inc's Quest Diagnostics position peaked at $43K in Q3 2021.
878 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Hudock Inc's 13F filing for Q4 2022, filed 8 Feb 2023.